TheresaMarieMicheleMD

Critical Care Medicine, Pleural Disease

Physician

Are you Dr. Michele?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 62 invites waiting!
Read the latest clinical news, personalized to your specialty.

Dr. Theresa Michele, MD is a pulmonologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and New Jersey.

Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 1994 - 1999
Johns Hopkins UniversityResidency, Internal Medicine, 1991 - 1994
Northeast Ohio Medical UniversityClass of 1991

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

PubMed

121 citations
Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.
Murali K. Matta, Jeffry Florian, Robbert Zusterzeel, Nageswara Rao Pilli, Vikram Patel
JAMA. 2020-01-21
165 citations
Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.
Murali K. Matta, Robbert Zusterzeel, Nageswara Rao Pilli, Vikram Patel, Donna A. Volpe
JAMA. 2019-06-04
33 citations
The Risks and Benefits of Indacaterol — The FDA's Review
Badrul A. Chowdhury, Sally Seymour, Theresa Michele, Anthony G. Durmowicz, Dongmei Liu
The New England Journal of Medicine. 2011-12-14

FDA Proposes to End Use of Oral Phenylephrine, Seeks Public CommentNovember 12th, 2024
FDA Proposes Ban on a ‘Useless’ Decongestant, PhenylephrineNovember 8th, 2024
FDA Moves to Pull Popular Decongestant from Shelves Amid Effectiveness ConcernsNovember 7th, 2024
Join now to see all